U.S. Hospitality Stock News

Upstart Holdings (UPST) is coming off a challenging stretch, with the stock down 20% over the past month and nearly 50% over the past year. Investors may be curious about what is driving these moves and where the company stands now. See our latest analysis for Upstart Holdings. Upstart Holdings’ share price has struggled for momentum lately, with a harsh 20% drop over the past month and nearly 50% lower total shareholder return over the past year. Although there have been solid three-year...

In late October 2025, Palo Alto Networks announced a series of next-generation AI security and automation products, including Prisma AIRS 2.0, Cortex AgentiX, and Cortex Cloud 2.0, designed to deliver comprehensive protection and autonomous workflow orchestration across the entire AI and cloud application lifecycle. A unique highlight of these launches is the integration of autonomous AI red teaming and model inspection, directly addressing the urgent need for robust enterprise guardrails as...

Ever wondered if Analog Devices is actually worth its current share price, or if the market is just caught up in the excitement? You are not alone. Today we will cut through the noise to get some answers. While the stock is up 3.0% over the past month and has delivered a solid 9.8% gain year to date, longer-term returns show an 83.6% rise over five years and 51.7% over the past three years, but only 7.0% in the last twelve months. Industry chatter has been buzzing about Analog Devices as it...

Synaptics (SYNA) just released its first quarter results, showing higher sales and a narrower net loss compared to last year. Alongside the report, management issued new guidance for the coming quarter. See our latest analysis for Synaptics. Synaptics shares have seen a bit of a rebound recently, notching a 1-month share price return of 10%. However, the year-to-date performance tells a more challenging story with shares still down 17%. Even with the steady flow of news, including earnings,...

Adeia (ADEA) drew attention after management cut its revenue and net income guidance for 2025, now forecasting both measures to come in well below previous expectations. This shift is particularly relevant for investors monitoring future earnings potential. See our latest analysis for Adeia. Adeia’s reduced guidance has left its mark on sentiment, with the share price slipping nearly 10% over the past month as investors react to lower earnings projections. Still, with a 1-year total...

General Motors (GM) shares have caught extra attention following the Trump administration's decision to extend tariff relief options for automakers. The extension eases cost pressures and encourages more investment in U.S. manufacturing capacity. See our latest analysis for General Motors. GM's share price has rallied an impressive 28% over the past month alone, fueled by tariff relief and fresh investment in U.S. plants. Recent headlines, including a major class action lawsuit and new model...

Avidity Biosciences, Inc. recently announced its third quarter 2025 earnings, reporting a net loss of US$174.44 million, more than double the loss from the same period last year. This considerable increase in losses may point to higher operating expenses or other challenges impacting the company's financial trajectory. With heightened net losses as a focal point, we'll explore how this development shapes Avidity Biosciences' investment narrative moving forward. We've found 16 US stocks that...

Lululemon athletica (LULU) has seen its stock make modest gains over the past week, up nearly 3%. Investors are watching closely given the stock's longer-term performance, which has lagged with a roughly 12% slide over the past 3 months. See our latest analysis for lululemon athletica. Lululemon athletica’s share price has recently ticked higher; however, the momentum fades in the bigger picture. The 1-year total shareholder return of negative 46.5% underscores continued challenges after a...

PPL Corporation recently reported strong third quarter 2025 results, showing robust increases in sales and net income compared to the prior year, and has narrowed its ongoing 2025 earnings guidance to US$1.78 to US$1.84 per share while maintaining its 2028 EPS and dividend growth targets. This combination of solid financial performance and a reaffirmed multi-year growth outlook demonstrates management’s confidence in the company’s long-term revenue and earnings potential. We'll explore how...

Tarsus Pharmaceuticals (TARS) just released its third quarter results, reporting a sharp increase in year-over-year revenue and a meaningful narrowing of net loss. The company also shared upbeat revenue guidance for the coming quarter, which signals ongoing momentum. See our latest analysis for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals’ latest wave of upbeat financial news has lit a fire under the share price, with a 6.65% gain in one day and a 41.73% share price return over the past...

Crown Holdings (CCK) just raised its full-year 2025 earnings and free cash flow forecasts, indicating a stronger outlook. The update follows continued growth in its European business along with a focus on shareholder returns. See our latest analysis for Crown Holdings. Crown Holdings’ upbeat 2025 outlook follows a robust year-to-date share price return of 22%, as the company ramped up buybacks and boosted shareholder returns. While its recent buyback activity caught investor attention, the...

Viper Energy (VNOM) just released its third quarter earnings, showing major growth in revenue compared to last year, but also reporting a shift to a net loss for the latest period. In addition, the company has wrapped up a considerable part of its multi-year stock buyback program, drawing fresh attention from investors. See our latest analysis for Viper Energy. Despite delivering sizable revenue growth over the year and completing a major share buyback, Viper Energy's momentum has cooled. The...

Patrick Industries (PATK) just released its third quarter 2025 earnings, and the numbers caught the attention of investors. The company posted higher sales compared to last year; however, profits and earnings per share moved lower. See our latest analysis for Patrick Industries. PATRICK Industries’ share price has shown solid momentum in 2025, with a year-to-date gain of 27.35%. Notably, its total shareholder return over the past year stands at 20.76%, and the longer-term performance remains...

Cleveland-Cliffs (CLF) just completed a $951 million equity offering and unveiled a strategic partnership with POSCO. These moves signal efforts to boost its capital position and expand within the evolving U.S.-Korea industrial landscape. See our latest analysis for Cleveland-Cliffs. Shares of Cleveland-Cliffs have seen some wild swings lately, down more than 21% over the past month, as investors digested the substantial equity raise and evolving industrial partnerships. Despite short-term...

SS Innovations International recently completed its first remote telesurgery using the SSi Mantra Tele Surgeon Console, with a surgeon in New Delhi operating on a patient at Manipal Hospital in Jaipur, approximately 185 miles away. This achievement illustrates the potential for remote robotic surgery to expand access to specialized medical care beyond traditional hospital settings. We’ll explore how SS Innovations’ breakthrough in remote telesurgery technology could impact its investment...

CBL & Associates Properties recently authorized a new US$25 million stock repurchase program, replacing its previous plan, and reported third-quarter results with significant increases in revenue and net income. This combination of capital returns and improved operational performance highlights CBL's focus on maximizing shareholder value while strengthening its retail property portfolio. We'll explore what these developments mean for CBL's investment narrative, especially as management...

Black Stone Minerals (BSM) has revealed a sweeping leadership succession plan set for January 2026, introducing new executive and board appointments. These changes came as the company reported steady Q3 revenue and net income year-over-year. See our latest analysis for Black Stone Minerals. The leadership shake-up and stable earnings appear to be stirring fresh interest in Black Stone Minerals, with the share price rebounding 6.4% over the past month after a tough start to the year. Looking...

CRISPR Therapeutics recently announced positive Phase 1 clinical trial results for CTX310, its in vivo CRISPR/Cas9 gene-editing therapy targeting ANGPTL3, showing deep and durable reductions in triglycerides and LDL cholesterol with a well-tolerated safety profile; these results were published in The New England Journal of Medicine and presented at the American Heart Association Scientific Sessions. This advancement not only highlights CRISPR Therapeutics' growing presence in cardiovascular...

As the U.S. stock market navigates a period of mixed performance, with major indices like the S&P 500 and Nasdaq showing slight declines following an early-week rally, investors are closely monitoring developments such as the potential end to the government shutdown. In this environment, identifying stocks that may be undervalued becomes crucial for investors seeking opportunities amid fluctuating tech stock performances and broader market shifts.

Amid a volatile market where major indices like the S&P 500 and Nasdaq have recently lost ground after a strong start to the week, investors are closely watching for signs of stability and growth. In such an environment, companies with high insider ownership can be particularly appealing, as they often signal confidence from those who know the business best and may offer robust revenue growth potential.

As the U.S. stock market experiences fluctuations, with tech stocks under pressure after a strong start to the week, investors are keenly observing opportunities for growth amid broader economic developments. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain a relevant investment area. These stocks can offer affordability and growth potential when backed by strong financials, and this article will explore several examples that stand...

As the U.S. market navigates a mixed landscape with tech stocks experiencing volatility and major indices like the S&P 500 and Nasdaq showing fluctuations, investors are keenly observing developments such as the potential end of the government shutdown. Amidst this backdrop, small-cap stocks, often overshadowed by their larger counterparts, present unique opportunities for those seeking growth potential in less-tracked areas of the market. Identifying these undiscovered gems requires a focus...

In early November 2025, Halozyme Therapeutics reported strong third-quarter results with year-to-date revenue of US$944.84 million and net income of US$458.48 million, while also raising its full-year 2025 revenue and royalty guidance. An additional insight is the company executed US$1.3 billion in new debt offerings and expanded its credit facility, indicating increased financial flexibility alongside a continuing share buyback program and an upcoming CFO transition. Given the upward...

Trinity Industries reported its third quarter 2025 financial results in late October, posting sales of US$300.8 million and net income of US$30.3 million, while raising and tightening its full-year earnings per share guidance to a range of US$1.55 to US$1.70. The move to increase guidance following mixed results highlights management's confidence in the company's outlook despite ongoing market and cost headwinds. We'll explore how Trinity's raised full-year earnings guidance may shape the...